Tacrolimus (FK506)/ Cyclosporine |
Calcineurin inhibition |
1. Hyperglycemia: Beta cell toxicity, decreased insulin secretion and insulin sensitivity PTDM [16,21,22,26,28,29].
2.
Hypogonadism/oligospermia: rarely [53].
3. Low bone density: Cyclosporine has strong evidence while TAC has equivocal effects [60-62,64]. |